Novartis is under renewed pressure from the international aid agency Medecins Sans Frontieres (MSF – Doctors Without Borders) to drop its legal challenge against India’s patent laws. As shareholders of the Swiss major met in Basel, MSF called on them to urge the company to drop its case against the Indian government. The latter relates to Novartis’ challenge to an Indian patent law, notably Section 3(d), which states that a modification of a known chemical composition is non-patentable.

Article Novartis again urged to drop India patent lawsuit